-
Medicare Beneficiaries See Pharmacists More Than PCPs
In a new JAMA Network Open paper, CP3 Associate Director Dr. Inma Hernandez & team show that Medicare beneficiaries encounter community pharmacists more often than PCPs. Pharmacists are uniquely positioned to be patient partners in prevention and disease management efforts.
Read the paper here -
US Is Paying Too Much for Remdesivir
Is the high price of remdesivir worth it? CP3 student Rohan Chalasani and CP3 Director Walid Gellad explain why it might not be.
Read the paper -
US Drug Prices Rose 3x Faster than Inflation
The latest paper from Drs. Hernandez, San-Juan-Rodriguez, Good, and Gellad examines the effect of manufacturer discounts on list prices of brand name drugs in the US. The authors found that, despite the discounts, prices still rose three times faster than inflation over the period of 2007-2018.
Read the paper here -
Dentists Prescribe Excessive Opioids
Dr. Katie Suda is lead author of a pivotal study examining patterns of excessive opioid prescribing among dentists.
Read more about the study
Improving the Quality, Safety and Efficiency of Medication Use
While prescription drugs are used by 80% of Americans, the improper, unsafe use of medications leads to billions of dollars of avoidable healthcare costs. The goal of the CP3 research program is to improve patient and prescriber decision-making, and inform the regulation and coverage of pharmaceuticals.
